Skip to content

Bacterial Risk

Want to stay updated on the latest pathogen inactivation news?
You can receive our highlights by subscribing to our newsletter.

ThumbnailCorash4Platelets

Bacterial safety of platelet components prepared with Amotosalen-UVA photochemical treatment. What can we conclude after 15 years routine experience?

Dr. Laurence M. Corash, M.D.
Cerus Corporation,
Concord, California, USA

EN DE ES PL RU

ThumbnailMetcalf2

Platelets

Bacterial contamination rate of platelet components by primary culture and residual risk associated with false negatives: results from two recent
meta-analyses

Dr. Ryan A. Metcalf
University of Utah and ARUP Laboratories
Utah, USA

EN DE ES PL RU

ThumbnailRamirezPlatelets

Merits and pitfalls of automated bacterial culture methods in improving bacterial safety of platelet concentrates


Dr. Sandra Ramirez-Arcos, PhD
Canadian Blood Services
Ottawa, Canada

EN DE ES PL RU

ThumbnailRichardWebinar1Platelets & Plasma

Bacterial safety of platelet components prepared with Amotosalen-UVA photochemical treatment. What can we conclude after 15 years routine experience?

 

Dr. Richard J. Benjamin, MBChB, PhD, FRCPath
Cerus Corporation,
Concord, California, USA

EN  

ThumbnailRamirez-1

Platelets

Timing of bacterial inactivation/testing

Dr. Sandra Ramirez-Arcos, PhD
Canadian Blood Services
Ottawa, Canada

EN DE   

ThumbnailMetcalf2Platelets

Estimating the risk associated with bacterial contamination of platelets

Dr. Ryan A. Metcalf, MD, CQA
University of Utah Health and ARUP Laboratories
Utah, USA

EN   

ThumbnailRamirezPlatelets 

Historical journey to improve screening of platelet components for bacterial contamination

Dr. Sandra Ramirez-Arcos, PhD
Canadian Blood Services and University of Ottawa
Ottawa, Canada

EN   

ThumbnailDamgaard

Platelets & Plasma

Periodontitis increases risk of viable bacteria in freshly drawn blood donations

Dr. Christian Damgaard, DDS, PhD
University of Copenhagen
Copenhagen, Denmark

EN   

ThumbnailHervig

Platelets & Plasma

Evolution of the level of blood safety and impact on patient safety: a historic perspective

Dr. Tor Hervig
Haugesund Hospital / University of Bergen
Bergen, Norway

EN   

ThumbnailRichard-1Platelets & Plasma

Transfusion transmitted bacterial infections in patients: why are they often undetected and underreported?

Dr. Richard J. Benjamin, MBChB, PhD, FRCPath
Cerus Corporation,
Concord, California, USA

EN DE PL ES RU

  

  

  

The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located.
Use of INTERCEPT Plasma or Platelets is contraindicated in patients with a history or allergic response to amotosalen or psoralens. Consult instructions for use for indications, contraindications, warnings, and precautions.

Cerus, INTERCEPT and the Cerus logo are trademarks of Cerus Corporation.

© 2023 Cerus Corporation. All Rights Reserved. MKT-EN 000157, v43.0